Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Expanded clinical and experimental use of SOX11 - using a monoclonal antibody

Figure 3

Flow cytometry-based assessment of SOX11 status in cell lines. Assessment of SOX11 status using flow cytometry analysis (bars) of B cell lymphoma and EOC cell lines reveal specific staining in cell lines positive for SOX11, including Z138, GRANTA 519, SP53, JEKO-1, REC-1, BJAB, KM3, OVCAR-3 and TOV-112D as assessed by RT-PCR analysis (diamonds). For each cell line, SOX11 ΔMFI was calculated as the difference between the mean fluorescence intensity (MFI) from SOX11-C1 antibody and the MFI from the control. (MFISOX11 – MFIcontrol). The relative SOX11 expression was calculated by scaling all data to the cell line with the lowest ΔMFI (DOHH-2).

Back to article page